Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancerJan Harder, Michael Geißler, Gabriele Ihorst et al.|British Journal of Cancer|2012Cited by 184
NeoFLOT: Multicenter phase II study of perioperative chemotherapy in resectable adenocarcinoma of the gastroesophageal junction or gastric adenocarcinoma-Very good response predominantly in patients with intestinal type tumorsChristoph Schulz, Volker Heinemann, Heribert Stauder et al.|International Journal of Cancer|2014Cited by 126
Klinische PathophysiologieW Siegenthaler, Nasser Semmo, Hubert E. Blum et al.|Unknown|2006Cited by 93